L'Oréal S.A. (EPA:OR)
Market Cap | 197.16B |
Revenue (ttm) | 43.49B |
Net Income (ttm) | 6.41B |
Shares Out | 534.32M |
EPS (ttm) | 11.95 |
PE Ratio | 30.88 |
Forward PE | 28.10 |
Dividend | 7.00 (1.90%) |
Ex-Dividend Date | May 5, 2025 |
Volume | 256,562 |
Average Volume | 329,013 |
Open | 367.50 |
Previous Close | 370.20 |
Day's Range | 364.85 - 369.85 |
52-Week Range | 316.30 - 447.15 |
Beta | 0.85 |
RSI | 44.31 |
Earnings Date | Jul 29, 2025 |
About L'Oréal
L'Oréal S.A., through its subsidiaries, manufactures and sells cosmetic products for women and men worldwide. The company operates through four divisions: Professional Products, Consumer Products, Luxe, and Dermatological Beauty. It offers skincare, make-up, hair colourants, haircare, perfumes, and hygiene products. The company provides its products under the L’Oréal Paris, Garnier, Maybelline New York, NYX Professional Makeup, Stylenanda, Essie, Dark & Lovely, Mixa, L’Oréal Professionnel Paris, Kérastase, Redken, Matrix, Pureology, Lancôme, Yv... [Read more]
Financial Performance
In 2024, L'Oréal's revenue was 43.49 billion, an increase of 5.60% compared to the previous year's 41.18 billion. Earnings were 6.41 billion, an increase of 3.63%.
Financial StatementsNews
L'Oreal: Why This Beauty Giant Is One Of My Top Picks (Rating Upgrade)

Nvidia's Generative AI To Fuel Hyper-Scalable 3D Rendering For L'Oréal
L’Oréal Groupe announced on Wednesday that it has partnered with Nvidia Corp . (NASDAQ: NVDA) to unlock AI’s potential in multiple aspects of beauty. Through this collaboration, L’Oréal and its partn...
Luxury skincare expansion: L’Oreal acquires majority stake in Medik8; announces 1 billion Euro deal
L'Oreal is set to acquire a majority stake in Medik8, a British skincare brand known for its vitamin A-focused products. This strategic move aims to bolster L'Oreal's presence in the thriving skincare...
L'Oréal acquires majority stake in British skincare brand Medik8

L'Oreal buys British skincare brand Medik8
L'Oreal is to acquire British skincare brand Medik8, its owner, Britain-based private equity firm Inflexion, said on Monday, boosting the French cosmetics giant's offering in the fast-growing dermatol...

L’Oreal sees Middle East and Southeast Asia as next growth engines as China slows: ‘Eventually demographics have to win’
Sales in SAPMENA, a region coined by L'Oreal that covers South Asia Pacific, Middle East, and North Africa, is the beauty brand's fastest growing region.
Luxury earnings: Former LVMH exec highlights 2 things differentiating the winners
Ralph Lauren posted better-than-expected fiscal fourth quarter results on the top and bottom lines, but warns growth could slow as tariffs hit later this year. Pauline Brown, former LVMH North America...
Take a tour inside L'Oreal's new American-based research and innovation center
CNBC's Charlotte Reed takes an exclusive tour of L'Oreal's new research and innovation center in Clark, New Jersey, as she learns about the latest technology developments at the world's largest cosmet...
L'Oréal: Outperforming The Beauty Sector In 2024, And 2025 Is Expected To Do The Same
L'Oréal S.A. (LRLCF) Q1 2025 Sales/ Trading Statement Call (Transcript)
L'Oréal Q1 sales improve 4.4% beating expectations

L'Oreal Sales Rise After Boost From Luxe Unit
L'Oréal Chief Executive Nicolas Hieronimus said he is optimistic on the outlook for the global beauty market despite economic and geopolitical tensions.

L'Oreal sales rise slightly, but US challenging
L'Oreal reported a rise in first-quarter sales on Thursday, beating expectations for slower growth, as strong demand for its creams and perfume in Europe helped counter challenging conditions in the U...
Meet Françoise Bettencourt Meyers, the L'Oréal heiress worth about $80 billion
L'Oréal heiress Françoise Bettencourt Meyers is stepping down from the company's board of directors in 2025 after nearly 30 years.
Inside L'Oreal's $160 million research and innovation facility
The world's largest beauty company, L'Oreal, has invested $160 million to revamp its North America Research & Innovation Center, its largest investment in R&I in its 110 years history, located in Clar...

L'Oreal CEO plays down the impact of U.S. tariffs, says he's 'not overly concerned'
L'OrealCEO Nicolas Hieronimus said he is "not overly concerned" over the impact of White House tariffs on L'Oreal.

L'Oreal recalls acne cream that may contain cancer-causing benzene
Makeup company L'Oréal S.A. issued a recall on all lots of acne cream Effaclar Duo due to concern that benzene, a known carcinogen, is in the product.
L'Oreal CEO: Tariff wars are never good for consumers
L'Oreal CEO Nicolas Hieronimus discusses the U.S. market, tariffs, European competitiveness and Chinese demand in an exclusive interview at the firm's newly opened R&I facility in New Jersey.
L'Oreal CEO: Consumer demand must be stimulated by innovation
L'Oreal CEO Nicolas Hieronimus discusses the company's $160 million investment in its new U.S. R&I facility in an exclusive interview with CNBC.

L'Oreal CEO: Tariff wars are never good for consumers
L'Oreal CEO Nicolas Hieronimus discusses the U.S. market, tariffs, European competitiveness and Chinese demand in an exclusive interview at the firm's newly opened R&I facility in New Jersey.

L'Oreal CEO: Consumer demand must be stimulated by innovation
L'Oreal CEO Nicolas Hieronimus discusses the company's $160 million investment in its new U.S. R&I facility in an exclusive interview with CNBC.

A Rip Van Winkle Portfolio: Invest In These Companies And Forget You Did It
The Rip Van Winkle portfolio advocates for long-term, buy-and-hold investing in companies with competitive advantages, reasonable valuations, and strong financial performance. Alphabet, Meta, and Alib...
L'Oreal: Downgrade To Hold As Organic Growth Outlook Is No Longer Great

Salon owner 'in limbo' over L'Oréal dispute delays
Rebecca Dowdeswell says it feels like there is no end in sight to her legal battle with the firm.